MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2967/jnumed.122.264041

Медицинская библиотека · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022

Prevalence and Outcomes of Cardiac Amyloidosis in All-Comer Referrals for Bone Scintigraphy.

Nitsche Christian, Mascherbauer Katharina, Calabretta Raffaella, Koschutnik Matthias, Dona Carolina, Dannenberg Varius, Hofer Felix, Halavina Kseniya, Kammerlander Andreas A, Traub-Weidinger Tatjana, Goliasch Georg, Hengstenberg Christian, Hacker Marcus, Mascherbauer Julia

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

The prevalence of cardiac amyloidosis (CA) in the general population and associated prognostic implications remain poorly understood. We aimed to identify CA prevalence and outcomes in bone scintigraphy referrals.

Methods

Consecutive all-comers undergoing 99mTc-3,3-diphosphono-1,2-propanodicarboxylic-acid (99mTc-DPD) bone scintigraphy between 2010 and 2020 were included. Perugini grade 1 was defined as low-grade uptake and grade 2 or 3 as confirmed CA. All-cause mortality, cardiovascular death, and heart failure hospitalization (HHF) served as endpoints.

Results

In total, 17,387 scans from 11,527 subjects (age, 61 ± 16 y; 63.0% women, 73.6% cancer) were analyzed. Prevalence of 99mTc-DPD positivity was 3.3% (n = 376/11,527; grade 1: 1.8%, grade 2 or 3: 1.5%), and was higher among cardiac than noncardiac referrals (18.2% vs. 1.7%). In individuals with more than 1 scan, progression from grade 1 to grade 2 or 3 was observed. Among patients with biopsy-proven CA, the portion of light-chain (AL)-CA was significantly higher in grade 1 than grade 2 or 3 (73.3% vs. 15.4%). After a median of 6 y, clinical event rates were: 29.4% mortality, 2.6% cardiovascular death, and 1.5% HHF, all independently predicted by positive 99mTc-DPD. Overall, adverse outcomes were driven by confirmed CA (vs. grade 0, mortality: adjusted hazard ratio [AHR] 1.46 [95% CI 1.12-1.90]; cardiovascular death: AHR 2.34 [95% CI 1.49-3.68]; HHF: AHR 2.25 [95% CI 1.51-3.37]). One-year mortality was substantially higher in cancer than noncancer patients. Among noncancer patients, also grade 1 had worse outcomes than grade 0 (HHF/death: AHR 1.45 [95% CI 1.01-2.09]), presumably because of longer observation and higher prognostic impact of early infiltration.

Conclusion

Positive 99mTc-DPD was identified in a substantial number of consecutive 99mTc-DPD referrals and associated with adverse outcomes.

Для цитирования: Nitsche Christian, Mascherbauer Katharina, Calabretta Raffaella, Koschutnik Matthias, Dona Carolina, Dannenberg Varius, Hofer Felix, Halavina Kseniya, Kammerlander Andreas A, Traub-Weidinger Tatjana, Goliasch Georg, Hengstenberg Christian, Hacker Marcus, Mascherbauer Julia. Prevalence and Outcomes of Cardiac Amyloidosis in All-Comer Referrals for Bone Scintigraphy.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2022. DOI: 10.2967/jnumed.122.264041.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.